Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
Dana-Farber Cancer Institute today announced the conclusion of the largest capital campaign in its history. Mission Possible: The Dana-Farber Campaign to Conquer Cancer raised $1.18 billion, making Dana-Farber the first hospital in New
England to launch and complete a $1 billion capital campaign.
The campaign met its $1 billion financial goal one year early last
September, and continued raising funds until its scheduled completion
date, Sept. 30, 2010, in order to further support the campaign
priorities and the mission to conquer cancer.
"It is gratifying and motivating that literally millions of gifts
from people and organizations have supported our mission to accelerate
the pace of cancer research and to promote the translation of scientific
advances into new life-saving therapies," said Dana-Farber President
Edward J. Benz Jr., MD. "The investments made in Dana-Farber during the
past seven years have generated unprecedented insights into the causes
and underlying mechanisms of cancer, giving us the knowledge and tools
needed to provide care that is personalized to each person's cancer."
The campaign was designed to raise financial support for four critical areas: construction of the Yawkey Center for Cancer Care; research and care; technology; and the Jimmy Fund and unrestricted funds.
The Yawkey Center, scheduled to open in January 2011, will enable
Dana-Farber to provide its trademark compassionate, family-centered care
to an increasing volume of patients, while also creating an environment
that fosters healing and facilitates innovative treatment that targets
the genetics of each patient's tumor.
Designed with advice from patients, families, and staff, the
14-story, 275,000 square foot state-of-the-art clinical care and
research facility will house 130 exam rooms, 137 infusion chairs, and 20
patient and family consultation rooms, as well as the Clinical Research
Center, which will conduct complex clinical trials and test new
scientific hypotheses in patients.
Gifts made during the campaign have helped establish a number of
centers critical to the development of personalized cancer care,
including the Center for Cancer Genome Discovery, Blais Proteomics Center, Lurie Family Imaging Center, Linde Program in Chemical Biology, Belfer Institute for Applied Cancer Science, and the Center for Novel Experimental Therapeutics.
The campaign's size and scope is proportionate to the growth of
Dana-Farber during the last decade. Between 2001 and 2009, outpatient
visits and infusions at Dana-Farber more than doubled, from nearly
128,000 to more than 292,000. The number of clinical trials available
to Dana-Farber patients increased nearly 80 percent, from 409 trials to
"As a two-time cancer survivor, I have firsthand appreciation of the
importance of expeditiously converting laboratory discoveries into new
treatments," said Larry Lucchino, president and CEO of the Boston Red
Sox and co-chair of the Mission Possible campaign. "Thanks to
the wide support of the campaign, Dana-Farber has the resources to
expand on its leadership role in translational, bench-to-bedside
research, which will mean more cancer patients will be given a much
better chance to become cancer survivors."
"Achieving the campaign's ambitious goal of raising more than $1
billion to support Dana-Farber's mission is extremely noteworthy, but
the campaign's real legacy will be measured in the number of lives saved
through the development of new treatments that are based on advances
made at Dana-Farber," said Josh Bekenstein, co-chair of the Mission Possible campaign and a managing director of Bain Capital, LLC.
To date, more than 2 million gifts of all sizes were received, with
121 gifts of $1 million or more, and 820 gifts of $100,000 or more.
Every Dana-Farber trustee has made a gift during the campaign period,
and 96 percent of Dana-Farber's senior faculty contributed very early
on, showing their confidence in what the campaign could accomplish.
Transformative gifts were received from many individuals and
organizations, including $183 million from seven Pan-Massachusetts
Challenge bike-a-thons, $50 million from Susan F. and Richard A. Smith,
$30 million from the Yawkey Foundation, $20 million from the Linde
Family Foundation, $16 million from the Lurie-NLM Marks Family
Foundation, $10 million from the Renee E. and Robert A. Belfer Family
Foundation, $10 million from The Charles A. Dana Foundation, and $10
million from the Friends of Dana-Farber Cancer Institute.
"The achievement of the campaign's fundraising goal is a testament to
the widespread support for Dana-Farber throughout New England and the
country, and it speaks to a collective confidence that with enough
resources, cancer can be conquered," said Susan Paresky, senior vice
president for the Division of Development and the Jimmy Fund.